Barclays acted as sole book running manager for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RVNC:
- Revance price target raised to $16 from $15 at Guggenheim
- Revance price target raised to $9 from $8 at Goldman Sachs
- Revance price target lowered to $20 from $42 at Piper Sandler
- Revance Therapeutics Renews Manufacturing Deal and Announces Executive Transition
- Revance sees FY24 product revenue at least $280M
